根据JAK2 V617F突变状态,定义基本血小板血的亚型和与真菌多细胞血的关系:一项前性研究
Peter J Campbell1, Linda M Scott, Georgina Buck
1Department of Haematology, University of Cambridge, UK.
Lancet (London, England)
|December 6, 2005
概括
在基本血栓细胞性病患者中,JAK2 V617F突变会与真多细胞性病产生生物连续性. 这种突变影响疾病特征和治疗反应,表明基因修饰剂发挥作用.
科学领域:
- 血液学 血液学 血液学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 简氏激酶2 (JAK2) V617F突变在骨髓增殖性瘤中普遍存在.
- 它的存在在多细胞血症真 (PV),基本血栓细胞血症 (ET) 和异常性骨髓纤维化 (IMF) 之间有所不同.
- 了解与JAK2 V617F突变相关的生物学区别和表型变异至关重要.
研究的目的:
- 调查携带JAK2 V617F突变的基本血栓细胞性病 (ET) 患者是否与没有这种突变的患者有生物学上的区别.
- 探索JAK2 V617F突变与不同疾病表型相关的原因.
主要方法:
- 利用基于PCR的敏感方法对806 ET患者的基因型进行JAK2 V617F突变.
- 在JAK2V617F阳性和V617F阴性ET患者之间比较实验室和临床特征,治疗反应和临床事件.
主要成果:
- 具有JAK2 V617F阳性的ET患者表现出与PV重叠的特征,包括血红蛋白和中性粒细胞数量升高,红色受体和颗粒受体增加,以及更高的静脉血栓和多细胞变异率.
- 突变阳性患者表现出较低的血清红素和费里丁水平.
- 与突变阴性对应物相比,JAK2 V617F阳性个体对基尿素治疗的敏感性增加.
结论:
- 具有JAK2 V617F突变的基本血栓塞瘤和真菌多细胞塞瘤代表了一个生物连续性.
- 红细胞瘤的程度很可能受到生理或遗传因素的调节.
- 这些发现突显了JAK2突变状态在理解MPN病原和临床行为的重要性.
相关概念视频
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:27Disorders of Erythrocytes
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
01:10Blood Typing
Understanding an individual's blood group is a critical component of transfusion medicine. It ensures compatibility in blood transfusions, organ transplants, and even during pregnancy. Determining these blood groups involves the ABO and Rh blood typing systems, utilizing specific antigens and corresponding anti-sera to identify an individual's blood type.
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target antigens A,...
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target antigens A,...
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...